These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 33451905

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.
    Zhang H, Watanabe R, Berry GJ, Tian L, Goronzy JJ, Weyand CM.
    Circulation; 2018 May 01; 137(18):1934-1948. PubMed ID: 29254929
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib.
    Wang A, Rahman NT, McGeary MK, Murphy M, McHenry A, Peterson D, Bosenberg M, Flavell RA, King B, Damsky W.
    J Allergy Clin Immunol; 2021 May 01; 147(5):1795-1809. PubMed ID: 33317858
    [Abstract] [Full Text] [Related]

  • 7. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L, Zhao C, Qin F, He ZY, Wang X, Zhong XN.
    Clin Exp Rheumatol; 2016 May 01; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. IL-21 induction of CD4+ T cell differentiation into Th17 cells contributes to bleomycin-induced fibrosis in mice.
    Lei L, Zhong XN, He ZY, Zhao C, Sun XJ.
    Cell Biol Int; 2015 Apr 01; 39(4):388-99. PubMed ID: 25492803
    [Abstract] [Full Text] [Related]

  • 12. The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis.
    Wang C, Oishi K, Kobayashi T, Fujii K, Horii M, Fushida N, Kitano T, Maeda S, Ikawa Y, Komuro A, Hamaguchi Y, Matsushita T.
    Int J Mol Sci; 2024 Jun 01; 25(11):. PubMed ID: 38892317
    [Abstract] [Full Text] [Related]

  • 13. Potential roles of interleukin-17A in the development of skin fibrosis in mice.
    Okamoto Y, Hasegawa M, Matsushita T, Hamaguchi Y, Huu DL, Iwakura Y, Fujimoto M, Takehara K.
    Arthritis Rheum; 2012 Nov 01; 64(11):3726-35. PubMed ID: 22833167
    [Abstract] [Full Text] [Related]

  • 14. A novel bispecific antibody alleviates bleomycin-induced systemic sclerosis injury.
    Yin Q, Pi X, Ren G, Liu Z, Liu H, Wang M, Hu C, Zhao H, Li D, Yin J.
    Int Immunopharmacol; 2020 Aug 01; 85():106644. PubMed ID: 32474387
    [Abstract] [Full Text] [Related]

  • 15. BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance.
    Matsushita T, Kobayashi T, Mizumaki K, Kano M, Sawada T, Tennichi M, Okamura A, Hamaguchi Y, Iwakura Y, Hasegawa M, Fujimoto M, Takehara K.
    Sci Adv; 2018 Jul 01; 4(7):eaas9944. PubMed ID: 30009261
    [Abstract] [Full Text] [Related]

  • 16. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
    Pamuk ON, Can G, Ayvaz S, Karaca T, Pamuk GE, Demirtas S, Tsokos GC.
    Clin Exp Rheumatol; 2015 Jul 01; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Generation of a novel CD30+ B cell subset producing GM-CSF and its possible link to the pathogenesis of systemic sclerosis.
    Higashioka K, Kikushige Y, Ayano M, Kimoto Y, Mitoma H, Kikukawa M, Akahoshi M, Arinobu Y, Horiuchi T, Akashi K, Niiro H.
    Clin Exp Immunol; 2020 Sep 01; 201(3):233-243. PubMed ID: 32538493
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions.
    Spalinger MR, Sayoc-Becerra A, Ordookhanian C, Canale V, Santos AN, King SJ, Krishnan M, Nair MG, Scharl M, McCole DF.
    J Crohns Colitis; 2021 Mar 05; 15(3):471-484. PubMed ID: 32909045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.